Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Patz, E. F.
Right arrow Articles by Herndon, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Patz, E. F., Jr.
Right arrow Articles by Herndon, J.
(Chest. 1998;113:1305-1311.)
© 1998 American College of Chest Physicians

Sclerotherapy for Malignant Pleural Effusions

A Prospective Randomized Trial of Bleomycin vs Doxycycline with Small-Bore Catheter Drainage

Edward F. Patz Jr. MD1; H. Page McAdams MD1; Jeremy J. Erasmus MD1; Philip C. Goodman MD, FCCP1; Donna K. Culhane MD1; Robert C. Gilkeson MD1; and James Herndon PhD1

1 From the Department of Radiology, Duke University Medical Center, Durham, NC.

Background: Malignant pleural effusions are a common problem for patients with metastatic disease. Most patients are treated with tube thoracostomy and sclerotherapy, although there remains no standard approach. The purpose of this study was to compare the efficacy of bleomycin with doxycycline sclerotherapy for the treatment of malignant pleural effusions using small-bore catheters.

Methods: All patients with a symptomatic malignant pleural effusion referred for chest tube drainage and sclerotherapy over a 2-year period were considered eligible. Using image guidance, a 14F self-retaining catheter was inserted into the pleural space and connected to continuous wall suction. When drainage fell below 200 mL/d, patients were randomized to 60 U of bleomycin or 500 mg of doxycycline sclerotherapy. Response at 30 days was determined.

Results: One hundred six patients were enrolled in the study. Fifteen men (29%) and 37 women (71%) with a mean age of 57 years received bleomycin sclerotherapy. Twenty-one of the 29 patients (72%) alive and evaluable at 30 days had successful sclerotherapy. Twenty-three men (43%) and 31 women (57%) with a mean age of 61 years received doxycycline sclerotherapy. Twenty-three of the 29 patients (79%) alive and evaluable at 30 days had successful sclerotherapy. There was no significant difference in response rates between doxycycline and bleomycin (p=0.760).

Conclusions: These data continue to support a role for small-bore chest drainage and sclerotherapy, although there was no significant difference in 30-day response rates between doxycycline and bleomycin.

Key Words: doxycycline • malignant pleural effusions • sclerotherapy • small-bore catheters

Submitted on July 11, 1997
Accepted on October 8, 1997




This article has been cited by other articles:


Home page
ChestHome page
A. R. Haas, D. H. Sterman, and A. I. Musani
Malignant Pleural Effusions: Management Options With Consideration of Coding, Billing, and a Decision Approach
Chest, September 1, 2007; 132(3): 1036 - 1041.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Tan, A. Sedrakyan, J. Browne, S. Swift, and T. Treasure
The evidence on the effectiveness of management for malignant pleural effusion: a systematic review.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 829 - 838.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
O. Dikensoy, Z. Zhu, E. Donnelly, G. T. Stathopoulos, K. B. Lane, and R. W. Light
Combination Therapy With Intrapleural Doxycycline and Talc in Reduced Doses Is Effective in Producing Pleurodesis in Rabbits
Chest, November 1, 2005; 128(5): 3735 - 3742.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
S. Bilaceroglu, Y. Guo, M. L. Hawthorne, Z. Zhu, G. T. Stathopoulos, K. B. Lane, and R. W. Light
Oral Forms of Tetracycline and Doxycycline Are Effective in Producing Pleurodesis
Chest, November 1, 2005; 128(5): 3750 - 3756.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
S. Sartori, P. Tombesi, D. Tassinari, P. Ceccotti, I. Nielsen, L. Trevisani, and V. Abbasciano
Sonographically Guided Small-Bore Chest Tubes and Sonographic Monitoring for Rapid Sclerotherapy of Recurrent Malignant Pleural Effusions
J. Ultrasound Med., September 1, 2004; 23(9): 1171 - 1176.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Sartori, D. Tassinari, P. Ceccotti, P. Tombesi, I. Nielsen, L. Trevisani, and V. Abbasciano
Prospective Randomized Trial of Intrapleural Bleomycin Versus Interferon Alfa-2b via Ultrasound-Guided Small-Bore Chest Tube in the Palliative Treatment of Malignant Pleural Effusions
J. Clin. Oncol., April 1, 2004; 22(7): 1228 - 1233.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. A. Spiegler, A. N. Hurewitz, and M. L. Groth
Rapid Pleurodesis for Malignant Pleural Effusions
Chest, June 1, 2003; 123(6): 1895 - 1898.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G Antunes, E Neville, J Duffy, and N Ali
BTS guidelines for the management of malignant pleural effusions
Thorax, May 1, 2003; 58(90002): ii29 - 38.
[Full Text]


Home page
Emerg. Med. J.Home page
J. Argall, J. Desmond, and K Mackway-Jones
Seldinger technique chest drains and complication rate
Emerg. Med. J., March 1, 2003; 20(2): 169 - 170.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
P. A. Kvale, M. Simoff, and U. B. S. Prakash
Palliative Care
Chest, January 1, 2003; 123(1_suppl): 284S - 311S.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
V.B. Antony, R. Loddenkemper, P. Astoul, C. Boutin, P. Goldstraw, J. Hott, F. Rodriguez Panadero, and S.A. Sahn
Management of malignant pleural effusions
Eur. Respir. J., August 1, 2001; 18(2): 402 - 419.
[Full Text] [PDF]


Home page
ThoraxHome page
G ANTUNES and E NEVILLE
Management of malignant pleural effusions
Thorax, December 1, 2000; 55(12): 981 - 983.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
Management of Malignant Pleural Effusions
Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1987 - 2001.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. H. DIACON, C. WYSER, C. T. BOLLIGER, M. TAMM, M. PLESS, A. P. PERRUCHOUD, and M. SOLER
Prospective Randomized Comparison of Thoracoscopic Talc Poudrage under Local Anesthesia versus Bleomycin Instillation for Pleurodesis in Malignant Pleural Effusions
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1445 - 1449.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
D. Bouros, M. Froudarakis, and N. M. Siafakas
Pleurodesis : Everything Flows
Chest, September 1, 2000; 118(3): 577 - 579.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American College of Chest Physicians.